• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧化型低密度脂蛋白受体1跨膜结构域内的突变影响氧化型低密度脂蛋白诱导的信号转导。

Mutation within the transmembrane domain of oxidized low-density lipoprotein receptor 1 influences oxidized low-density lipoprotein-induced signal transduction.

作者信息

Ma Zhen, Xu Ran, Lu Jing, Huang Xiong, Jia Hao, Ding Zhiwen, Yuan Jie, Zou Yunzeng

机构信息

Institutes of Biomedical Sciences, Fudan University, Shanghai, China.

Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Shanghai, China.

出版信息

Innate Immun. 2025 Jan-Dec;31:17534259251350447. doi: 10.1177/17534259251350447. Epub 2025 Jun 16.

DOI:10.1177/17534259251350447
PMID:40518921
Abstract

ObjectiveTo investigate the important active sites within the NTFs to affect the interaction of oxidized low-density lipoprotein (ox-LDL) with its receptor, OLR1.MethodsSimulation analysis online was performed to generate various OLR1 chimeras, truncation mutants, and site-specific mutations. They were transfected in COS-7 cells and subjected to ox-LDL stimulations to observe the different reactions. Immunoprecipitation-mass spectrometry (IP-MS) was performed to show what proteins combined with OLR1 mutants in reaction to ox-LDL. Lipid uptake in human monocytes (THP-1) originated foam cells overexpressing somatic mutant of OLR1 were also determined. Further studies focusing on these regions were conducted using truncation mutants and site-specific mutants such as G43A, V44A, L45A, C46A, and L47A.ResultsAmino acids within the TM were highly conserved, spanning amino acids 35 to 57. The induction of intracellular p-ERK1/2 in response to ox-LDL stimulation was highly promoted in Chimera 3 possessing the TM from OLR1 like OLR1/WT ( < 0.05). Sequence alignment revealed two conserved regions within the TM of OLR1, Leu45-Cys46-Leu47 and Val55-Leu56-Gly57. Western blot showed that most of the TM changes ablated ERK1/2 activation in response to ox-LDL stimulation ( < 0.05). One human somatic mutation at L45F revealed significantly lower p-ERK1/2 levels with enhanced intake of ox-LDL in THP-1-derived foam cells than the control cells ( < 0.05). L45A and C46A molecular complexes were identified. After ox-LDL stimulation, these underlined interactions with keratins, namely KRT2 and KRT6A.ConclusionThese findings emphasize the vital role of the TM in the interactions between OLR1 and ox-LDL and point to an exciting possibility that signal transduction induced by ox-LDL through its receptor OLR1 may involve complex interactions with cytoskeletal proteins.

摘要

目的

研究神经毒素因子(NTFs)中影响氧化型低密度脂蛋白(ox-LDL)与其受体OLR1相互作用的重要活性位点。

方法

进行在线模拟分析以生成各种OLR1嵌合体、截短突变体和位点特异性突变体。将它们转染到COS-7细胞中并进行ox-LDL刺激,以观察不同反应。进行免疫沉淀-质谱分析(IP-MS)以显示在ox-LDL反应中与OLR1突变体结合的蛋白质。还测定了过表达OLR1体细胞突变体的人单核细胞(THP-1)来源的泡沫细胞中的脂质摄取。使用截短突变体和位点特异性突变体如G43A、V44A、L45A、C46A和L47A对这些区域进行了进一步研究。

结果

跨膜区(TM)内的氨基酸高度保守,跨度为第35至57位氨基酸。在具有与OLR1/WT相似的OLR1跨膜区的嵌合体3中,ox-LDL刺激引起的细胞内p-ERK1/2的诱导显著增强(<0.05)。序列比对揭示了OLR1跨膜区内的两个保守区域,Leu45-Cys46-Leu47和Val55-Leu56-Gly57。蛋白质印迹显示,大多数跨膜区变化消除了ox-LDL刺激引起的ERK1/2激活(<0.05)。在L45F处的一个人类体细胞突变显示,与对照细胞相比,THP-1来源的泡沫细胞中p-ERK1/2水平显著降低,ox-LDL摄取增加(<0.05)。鉴定出L45A和C46A分子复合物。ox-LDL刺激后,这些与角蛋白即KRT2和KRT6A的下划线相互作用。

结论

这些发现强调了跨膜区在OLR1与ox-LDL相互作用中的重要作用,并指出了一个令人兴奋的可能性,即ox-LDL通过其受体OLR1诱导的信号转导可能涉及与细胞骨架蛋白的复杂相互作用。

相似文献

1
Mutation within the transmembrane domain of oxidized low-density lipoprotein receptor 1 influences oxidized low-density lipoprotein-induced signal transduction.氧化型低密度脂蛋白受体1跨膜结构域内的突变影响氧化型低密度脂蛋白诱导的信号转导。
Innate Immun. 2025 Jan-Dec;31:17534259251350447. doi: 10.1177/17534259251350447. Epub 2025 Jun 16.
2
Ertugliflozin attenuates atherosclerosis in nondiabetic ApoE mice by upregulating ABCA1 and LDLR via the PPARγ/LXRα pathway.依鲁格列净通过PPARγ/LXRα途径上调ABCA1和LDLR,减轻非糖尿病ApoE小鼠的动脉粥样硬化。
Biochim Biophys Acta Mol Basis Dis. 2025 Oct;1871(7):167927. doi: 10.1016/j.bbadis.2025.167927. Epub 2025 May 24.
3
Circulating Level of Oxidized Low-Density Lipoprotein Correlates with Cerebral Blood Flow in Patients with White Matter Hyperintensities.氧化型低密度脂蛋白的循环水平与白质高信号患者的脑血流量相关。
Neurol India. 2025 Jul 1;73(4):732-739. doi: 10.4103/neurol-india.Neurol-India-D-23-00531. Epub 2025 Jul 24.
4
Mechanisms and consequences of myeloid adhesome dysfunction in atherogenesis.动脉粥样硬化中髓系黏附体功能障碍的机制及后果
Cardiovasc Res. 2025 Apr 15;121(1):62-76. doi: 10.1093/cvr/cvae223.
5
Galactin-8 DNA methylation mediates macrophage autophagy through the MAPK/mTOR pathway to alleviate atherosclerosis.半乳糖凝集素-8 DNA甲基化通过MAPK/mTOR途径介导巨噬细胞自噬以减轻动脉粥样硬化。
Sci Rep. 2025 Jan 2;15(1):603. doi: 10.1038/s41598-024-85036-1.
6
USP7 Stabilizes USF1 to Aggravate ox-LDL-Induced Endothelial Injury Through the MYD88/NF-κB Pathway in Atherosclerosis.USP7通过MYD88/NF-κB途径稳定USF1以加重动脉粥样硬化中氧化低密度脂蛋白诱导的内皮损伤。
Appl Biochem Biotechnol. 2025 Jul 18. doi: 10.1007/s12010-025-05312-2.
7
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
8
Ox-LDL Induces Neuron Apoptosis and Worsens Neurological Outcomes in aSAH via Fas/FADD Pathway.氧化低密度脂蛋白通过Fas/FADD途径诱导蛛网膜下腔出血患者神经元凋亡并恶化神经功能预后。
Mol Neurobiol. 2025 Apr 8. doi: 10.1007/s12035-025-04912-7.
9
Iron-dependent lysosomal LDL oxidation induces the expression of scavenger receptor A in human THP-1 monocytes.铁依赖性溶酶体低密度脂蛋白氧化诱导人THP-1单核细胞中清道夫受体A的表达。
FEBS Open Bio. 2025 Aug;15(8):1246-1266. doi: 10.1002/2211-5463.70048. Epub 2025 May 11.
10
Extracellular vesicle-derived miR-146a as a novel crosstalk mechanism for high-fat induced atherosclerosis by targeting SMAD4.细胞外囊泡衍生的miR-146a通过靶向SMAD4作为高脂诱导动脉粥样硬化的一种新型串扰机制。
J Adv Res. 2024 Aug 8. doi: 10.1016/j.jare.2024.08.012.

本文引用的文献

1
ESR1 Fusions Invoke Breast Cancer Subtype-Dependent Enrichment of Ligand-Independent Oncogenic Signatures and Phenotypes.ESR1 融合导致依赖配体的致癌信号和表型在乳腺癌亚型中富集。
Endocrinology. 2024 Aug 27;165(10). doi: 10.1210/endocr/bqae111.
2
LOX-1 variants modulate the severity of cardiovascular disease: state of the art and future directions.LOX-1 变体调节心血管疾病的严重程度:最新进展和未来方向。
Mol Cell Biochem. 2024 Sep;479(9):2245-2254. doi: 10.1007/s11010-023-04859-0. Epub 2023 Oct 3.
3
Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal.
在 cBioPortal 中分析和可视化 AACR 项目 GENIE 生物制药协作的纵向基因组和临床数据。
Cancer Res. 2023 Dec 1;83(23):3861-3867. doi: 10.1158/0008-5472.CAN-23-0816.
4
DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update).DAVID:一个用于基因列表功能富集分析和功能注释的网络服务器(2021 更新)。
Nucleic Acids Res. 2022 Jul 5;50(W1):W216-W221. doi: 10.1093/nar/gkac194.
5
Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer.胆固醇代谢失衡导致对铁死亡的抵抗,从而增加癌症的致瘤性和转移能力。
Nat Commun. 2021 Aug 24;12(1):5103. doi: 10.1038/s41467-021-25354-4.
6
SARS-CoV-2 infection susceptibility influenced by ACE2 genetic polymorphisms: insights from Tehran Cardio-Metabolic Genetic Study.SARS-CoV-2 感染易感性受 ACE2 基因多态性影响:来自德黑兰心脏代谢遗传研究的见解。
Sci Rep. 2021 Jan 15;11(1):1529. doi: 10.1038/s41598-020-80325-x.
7
Design of an engineered ACE2 as a novel therapeutics against COVID-19.设计一种工程化的血管紧张素转换酶2作为抗2019冠状病毒病的新型疗法。
J Theor Biol. 2020 Nov 21;505:110425. doi: 10.1016/j.jtbi.2020.110425. Epub 2020 Jul 29.
8
Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects.在核质界面干扰 ERK 二聚体化可靶向病理性 ERK1/2 信号传导而无心脏毒性副作用。
Nat Commun. 2020 Apr 7;11(1):1733. doi: 10.1038/s41467-020-15505-4.
9
The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases.肠道微生物群及其在动脉粥样硬化和相关心血管疾病发展中的作用。
Nutrients. 2020 Feb 26;12(3):605. doi: 10.3390/nu12030605.
10
Atherosclerosis.动脉粥样硬化。
Nat Rev Dis Primers. 2019 Aug 16;5(1):56. doi: 10.1038/s41572-019-0106-z.